The new National HHT Diagnosis and Treatment Initiative will provide 15 Centers of Excellence (CoE), including The University of North Carolina’s, with federal funding for the first time. HHT, a genetic disorder that causes some blood vessel to not develop properly, is the second most common genetic bleeding disorder in the United States. These funds will … Continued

Raj Kasthuri, MD, MBBS, co-authored a publication in the Annals of Internal Medicine titled Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization. Patients hospitalized with COVID-19 have an increased incidence of thromboembolism. The role of extended thromboprophylaxis after hospital discharge is unclear. To determine whether anticoagulation is superior to placebo in reducing death and … Continued

Cassi Frank, MMSc, PA-C, works with the benign hematology group at UNC Eastowne as a physician assistant. She is also a graduate student and mother who enjoys reading, playing the piano and all things chocolate!  What is your role in the Department and what patients do you serve? I am a physician assistant in the … Continued

Anyone is welcome to attend this event! Registration is not needed.

Medicine, like any other scientific field, cannot progress forward without the hard work of new, cutting-edge researchers. In the Department of Medicine, three physician scientist trainees are working to improve the lives of patients who have inflammatory bowel disease, cancer, and food allergies. In light of their promising, hard work, all three have received support … Continued

Are astronauts more likely to develop blood clots during space missions due to zero gravity? That’s the question NASA is trying to answer with help from UNC School of Medicine’s Stephan Moll, MD, professor in the Division of Hematology within the UNC Department of Medicine. A new publication in Vascular Medicine shows the results of an … Continued

As an assistant professor in the Divisions of Hematology and Geriatric Medicine, and a board-certified Geriatric-Hematologist, Dr. Shakira J. Grant, MBBS, is no stranger to success, but she has had to overcome many challenges along the way. Now, selected for the 2022 Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) cohort, she … Continued

March is Deep-Vein Thrombosis (DVT) Awareness Month, a public health initiative that seeks to aid understanding of a commonly occurring and potentially life-threatening medical condition among the general population. DVT is commonly referred to as a blood clot (thrombus) that forms in one or more veins located deep inside the body. Did you know, almost one … Continued

Nigel Key, MB, ChB, FRCP has been awarded a 5-year, $2.2 million T32 grant from the National Heart, Lung, and Blood Institute (NHLBI). Now closely aligned with the benign hematology research areas of focus in the Blood Research Center (hemostasis, thrombosis and sickle cell disease), the program will continue to recruit MD and PhD trainees … Continued

Jeremy Meier, MD, fellow in the division of hematology, Benjamin G. Vincent, MD, assistant professor in hematology, and Jonathan S. Serody, MD, chief of the division of hematology, are authors of the review “B Cell Function in the Tumor Microenvironment,” soon to be published in the Annual Review of Immunology. First author is Stephanie M. … Continued

For patients with chronic lymphocytic leukemia (CLL), minimal residual disease (MRD) has emerged as a highly sensitive indicator of disease burden during and at the end of treatment, and has correlated with time-to-event outcomes. Use of MRD has shown promise for guiding duration of treatment for CLL patients on time-limited therapy. “MRD measurement is not … Continued

In a session titled “Hemophilia Update: Our Cup Runneth Over,” presented at the 2021 annual meeting of the American Society of Hematology (ASH), experts in the treatment of bleeding disorders discussed the optimal use of factor concentrates in people with hemophilia, new and investigational alternatives to factor concentrates, and the promise of long-time control or … Continued